Snowball logo
logo
TXMD

TherapeuticsMD, Inc

TXMD • NASDAQ
$1.80$0.00  (0%)
Estimate
EPS
-0.03
Beta
0.647
Growth
Revenue, YoY
-8.72%
Net income, YoY
-71.87%
FCF, YoY
137.65%
About the company
Ticker
TXMD
ISIN
US88338N1072
Country
United States of America
Sector (GICS)
Healthcare
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Frequently asked questions

What sector does TherapeuticsMD, Inc (TXMD) operate in?

TherapeuticsMD, Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is TherapeuticsMD, Inc (TXMD) current stock price?

As of the latest data, TherapeuticsMD, Inc stock price is $1.80, with a previous close of $1.80.

What is TherapeuticsMD, Inc (TXMD) current market capitalization?

TherapeuticsMD, Inc market cap is approximately 20.83 million.

What is TherapeuticsMD, Inc (TXMD) Earnings Per Share (EPS)?

The trailing EPS is -$0.03.

What is TherapeuticsMD, Inc (TXMD) EBITDA?

TherapeuticsMD, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -474.00 thousand.

Does TherapeuticsMD, Inc (TXMD) pay dividends?

No. TherapeuticsMD, Inc does not pay a dividend.

What is TherapeuticsMD, Inc (TXMD) beta (volatility) score?

TherapeuticsMD, Inc has a beta of 0.647, indicating lower volatility than the overall market.